Internationalising to create Firm Specific Advantages: Leapfrogging strategies of U.S. Pharmaceutical firms in the 1930s and 1940s & Indian Pharmaceutical firms in the 1990s and 2000s
Athreye, Suma and Godley, Andrew (2008). Internationalising to create Firm Specific Advantages: Leapfrogging strategies of U.S. Pharmaceutical firms in the 1930s and 1940s & Indian Pharmaceutical firms in the 1990s and 2000s. UNU-MERIT.
Document type:
Report
Collection:
-
Attached Files (Some files may be inaccessible until you login with your UNU Collections credentials) Name Description MIMEType Size Downloads wp2008-051.pdf PDF 
application/pdf 344.66KB -
Author Athreye, Suma
Godley, AndrewTitle Internationalising to create Firm Specific Advantages: Leapfrogging strategies of U.S. Pharmaceutical firms in the 1930s and 1940s & Indian Pharmaceutical firms in the 1990s and 2000s Publication Date 2008 Publisher UNU-MERIT Abstract Internationalisation is a useful strategy to gain firm specific advantages during periods of technological discontinuity. The pharmaceutical industry offers us two such episodes as examples: when the antibiotics revolution was beginning and when the possibilities of genetic routes to new drug discovery were realised. This paper compares the strategies adopted by laggard U.S. firms scrambling to gain capabilities in antibiotics, and Indian firms equally eager to acquire positions in new biotechnology based drugs and shows that both groups used internationalisation strategies to gain technological advantages and build up their firm specific advantages. Keyword Technological leapfrogging
Internationalization
Indian pharmaceutical industry
Antibiotics revolution
US pharmaceuticalsJEL F2
L2
L6
N8
O3Copyright Holder UNU-MERIT Copyright Year 2008 ISSN 1871-9872 -
Citation counts 
Search Google Scholar
Access Statistics: 853 Abstract Views, 458 File Downloads - Detailed Statistics Created: Wed, 11 Dec 2013, 17:24:29 JST